Has Andrew Kirsch received payments from drug or device companies?

Yes. Drug and device makers reported $320,221 in general payments to Andrew Kirsch across 239 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Kirsch did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Kirsch come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Kirsch

Pediatric Urology · Atlanta, GANPI 1336243898

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Palette Life Sciences, Inc. at 58.0% of the total.

$320,221in general payments, 2019–2025

Across 239 payments — averaging $1339.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Palette Life Sciences, Inc.$186K
Teleflex LLC$131K
Intuitive Surgical$985
Boston Scientific$834
Conmed Corporation$234
Sumitomo Pharma America, Inc.$227
plus $1K from 24 others

What the payments were for

Consulting fees$182,22457%
Speaking & faculty fees$106,54433%
Grants$10,0003%
Travel & lodging$9,2893%
Food & beverage$11,4104%
Education$7550%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Palette Life Sciences, Inc.	87	$185,690
Teleflex LLC	78	$130,838
Intuitive Surgical	4	$985
Boston Scientific	10	$834
Conmed Corporation	2	$234
Sumitomo Pharma America, Inc.	9	$227
Accord Healthcare, Inc.	1	$206
Bayer	10	$187
Merck	6	$168
C. R. Bard, Inc. & Subsidiaries	3	$138
Myovant Sciences Inc.	1	$115
Blue Earth Diagnostics	3	$71
Novo Nordisk	2	$69
Coloplast	4	$66
Urogen Pharma, Inc.	2	$52
Bracco Diagnostics Inc.	1	$43
Alnylam Pharmaceuticals Inc.	2	$41
Dendreon Pharmaceuticals LLC	1	$31
Tolmar, Inc.	1	$28
Ferring Pharmaceuticals Inc.	1	$23
Endo Pharmaceuticals Inc.	1	$23
Progenics Pharmaceuticals, Inc.	1	$22
Neotract Inc.	1	$21
AstraZeneca	1	$21
Agiliti Surgical, Inc.	1	$20
Axonics, Inc.	1	$17
Convatec Inc.	1	$16
Ambu Inc.	1	$15
Olympus America Inc.	1	$15
Travere Therapeutics, Inc.	2	$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric urology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Other pediatric urology in Atlanta

Hal ScherzAtlanta$51K
Emily BlumAtlanta$19K
Michael Garcia-RoigAtlanta$5K
Shuvro deAtlanta$4K
James ElmoreAtlanta$2K
Edwin SmithAtlanta$1K
Ricardo Arceo OlaizAtlanta$951
Wolfgang CerwinkaAtlanta$315
James PikeAugusta$7K
Amanda RainesAugusta$2K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →